Are Anacor Pharmaceuticals Inc(ANAC), Repligen Corporation(RGEN) and Alere Inc(ALR) Overvalued Or Just Aiming For New Heights?

Posted by admin March 16, 2015 0 Comment 908 views

New York, NY – GDP INSIDER  –  03/16/2015.

This article discusses three companies: Anacor Pharmaceuticals Inc(NASDAQ:ANAC), Repligen Corporation(NASDAQ:RGEN) and Alere Inc(NYSE:ALR)

Anacor Pharmaceuticals Inc(NASDAQ:ANAC) soared to reach a new 52 weeks high of $56.98 on Friday before falling back to close up 14.72% or $7.14 at $55.66 on heavy trading of 2.263 million shares. The small molecule therapy biopharmaceutical company made the gains after releasing its fourth quarter and full year financial results which showed a much smaller Q4 loss of $0.24 per share, compared to the market consensus estimate of a loss of $0.59. Sales were also much higher at $9.60 million versus expected revenue of $4.70 million making it a solid hold for now.

Can Anacor Pharmaceuticals Inc Climb Even Higher? Delve Into The Details With Free ANAC Analysis.   

Repligen Corporation(NASDAQ:RGEN) continued its strong rally hitting a 52 week high of $32.19 before closing up 16.74% or $4.49 to close at $31.31 on Friday, with more than 2.227 million shares trading hands, compared to its three month average trading volume of 0.360 million. The gains came after the life sciences company reported its fourth quarter and full year financial results showing 2014 sales up 27% at $60.4 million compared to $47.5 million for 2013. Repligen Corporation also forecast further sales growth of between 19% and 24% in 2015, making the stock a strong hold and potential buy.

Is Now The Right Time To Invest In Repligen Corporation? Take A Closer Look With Free RGEN Analysis.

 Alere Inc(NYSE:ALR) continued to climb hitting a 52 week high of $49.47 on Friday, before ending the day up 3.18% or $1.51 at $49.06 on very active trading of 2.035 million shares, compared to its three month average trading volume of 0.630 million. The developer and manufacturer of medical diagnostic products has been outperforming the S&P 500 so far this year, up 29.10% year to date compared to the S&P 500 which is down 0.27% for the same period. However, with RSI of 76.79 the stock may correct downwards before it goes higher making it a hold at the moment.

Will Alere Inc Continue To Beat The Index? Find Everything You Need To Know In Our Free ALR Analysis.

About UltimateStockAlerts provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment